A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/48 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2761120
Disclosed are methods and treatment regimes that include the administration of immunconjugates targeting CD138 to combat diseases. The immunoconjugate is either used as the sole active ingredient, as part of a treatment regime or as part of an anticancer combination.
Cette invention concerne des méthodes et des schémas thérapeutiques consistant à administrer des immunoconjugués ciblant l'antigène CD138 pour lutter contre les maladies. L'immunoconjugué peut être utilisé comme principe actif unique, faire partie d'un schéma thérapeutique ou d'un protocole de polychimiothérapie antinéoplasique.
Aigner Silke
Bruecher Christoph
Czeloth Niklas
Daelken Benjamin
Engling Andre
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Biotest Ag
Immunogen Inc.
LandOfFree
Uses of immunoconjugates targeting cd138 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Uses of immunoconjugates targeting cd138, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Uses of immunoconjugates targeting cd138 will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2040420